LXR agonist modifies neuronal lipid homeostasis and decreases PGD2 in the dorsal root ganglia in western diet-fed mice.

LXR agonist modifies neuronal lipid homeostasis and decreases PGD2 in the dorsal root ganglia in western diet-fed mice.
复制标题

DOI:
10.1038/s41598-022-14604-0
复制
发表时间:
2022-06-24
期刊:
影响因子:
4.6
通讯作者:
Mansuy-Aubert, Virginie
Mansuy-Aubert, Virginie
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Elshareif, Nadia;Gavini, Chaitanya K.;Mansuy-Aubert, Virginie

文献摘要

参考文献

被引文献

相似文献

周围神经病变的患病率在糖尿病和超重人群中很高。慢性神经性疼痛是周围神经病变的一种症状,是导致生活质量差的主要致残症状。糖尿病和糖尿病前期个体的葡萄糖管理通常不能减少或改善疼痛症状,因此,探索其他机制以确定有效的治疗方法是必要的。大量的证据表明,脂质信号可能是一个可行的目标管理周围神经病变的肥胖个体。核转录因子肝X受体(LXR)是已知的脂质稳态、磷脂重塑和炎症的调节剂。值得注意的是,使用合成激动剂GW3965激活LXR延迟了啮齿动物中西方饮食(WD)诱导的异常性疼痛。为了进一步了解LXR作用的神经生物学基础,我们使用翻译核糖体亲和纯化,并评估了用LXR激动剂GW3965处理的WD喂养小鼠感觉神经元的翻译组学变化。我们还观察到,GW3965降低前列腺素水平和减少游离脂肪酸含量,同时增加溶血磷脂酰胆碱,磷脂酰胆碱,和胆固醇酯物种的背根神经节(DRG)的感觉神经元。这些数据表明,新的下游相互作用机制,修改后的GW3965治疗DRG神经元脂质。
The prevalence of peripheral neuropathy is high in diabetic and overweight populations. Chronic neuropathic pain, a symptom of peripheral neuropathy, is a major disabling symptom that leads to a poor quality of life. Glucose management for diabetic and prediabetic individuals often fail to reduce or improve pain symptoms, therefore, exploring other mechanisms is necessary to identify effective treatments. A large body of evidence suggest that lipid signaling may be a viable target for management of peripheral neuropathy in obese individuals. The nuclear transcription factors, Liver X Receptors (LXR), are known regulators of lipid homeostasis, phospholipid remodeling, and inflammation. Notably, the activation of LXR using the synthetic agonist GW3965, delayed western diet (WD)-induced allodynia in rodents. To further understand the neurobiology underlying the effect of LXR, we used translating ribosome affinity purification and evaluated translatomic changes in the sensory neurons of WD-fed mice treated with the LXR agonist GW3965. We also observed that GW3965 decreased prostaglandin levels and decreased free fatty acid content, while increasing lysophosphatidylcholine, phosphatidylcholine, and cholesterol ester species in the sensory neurons of the dorsal root ganglia (DRG). These data suggest novel downstream interplaying mechanisms that modifies DRG neuronal lipid following GW3965 treatment.
DOI: 10.7554/elife.06328
发表时间: 2015-04-21
期刊: eLife
影响因子: 7.7
作者:
Hashidate-Yoshida T;Harayama T;Hishikawa D;Morimoto R;Hamano F;Tokuoka SM;Eto M;Tamura-Nakano M;Yanobu-Takanashi R;Mukumoto Y;Kiyonari H;Okamura T;Kita Y;Shindou H;Shimizu T
通讯作者: Shimizu T
DOI: 10.1530/joe-12-0356
发表时间: 2013-01
期刊: The Journal of endocrinology
影响因子: --
作者:
Hinder LM;Vivekanandan-Giri A;McLean LL;Pennathur S;Feldman EL
通讯作者: Feldman EL
DOI: 10.1016/j.pain.2011.01.033
发表时间: 2011-05-01
期刊: PAIN
影响因子: 7.4
作者:
Ebersberger, Andrea;Natura, Gabriel;Schaible, Hans-Georg
通讯作者: Schaible, Hans-Georg
DOI: 10.2337/diacare.27.7.1591
发表时间: 2004-07-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Gregg, EW;Sorlie, P;Geiss, L
通讯作者: Geiss, L
DOI: 10.1172/jci92117
发表时间: 2018-06-01
影响因子: 15.9
作者:
Jayaraj, Nirupa D.;Bhattacharyya, Bula J.;Menichella, Daniela M.
通讯作者: Menichella, Daniela M.